P771: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS ON RAVULIZUMAB/ECULIZUMAB SHOWED HEMOGLOBIN RESPONSE SUPERIORITY WITH ADD-ON DANICOPAN VS PLACEBO

• Jong Wook Lee,
• Morag Griffin,
• Jin Seok Kim,
• Lily L L Wong,
• Caroline Piatek,
• Deepak Jain,
• Peng Liu,
• Gleb Filippov,
• Flore Sicre de Fontbrune,
• Antonio Maria Risitano,
• Austin Kulasekararaj

Affiliations

Jong Wook Lee

1 Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea

Morag Griffin

2 Leeds Teaching Hospitals

Jin Seok Kim

3 Yonsei University College of Medicine, Severance Hospital

Lily L L Wong

4 Queen Elizabeth Hospital, Kota Kinabalu

Caroline Piatek

5 University of Southern California/ LAC+USC Medical Center

Deepak Jain

6 Alexion, AstraZeneca Rare Disease

Peng Liu

6 Alexion, AstraZeneca Rare Disease

Gleb Filippov

6 Alexion, AstraZeneca Rare Disease

Flore Sicre de Fontbrune

7 Centre de Référence Aplasie Médullaire, Service d’Hématologie Greffe, Assistance Publique des Hôpitaux de Paris, Hôpital Saint-Louis

Antonio Maria Risitano

8 Federico II University of Naples and AORN Moscati

Austin Kulasekararaj

9 King’s College Hospital-NHS Foundation Trust, NIHR/Wellcome King’s Clinical Research Facility, London, UK and King’s College London